Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

US Patent 4575507 · Granted Mar 11, 1986

Estimated economic value: $22,894,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-Pyk2 antibodies2013
Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke2001
Spiro-heteroazalones for treatment of diabetic complications1991
Hydroxyacetic acid derivatives for the treatment of diabetic complications1989
Spiro-succinimides for treatment of diabetes complications1988
Sprio-imidazolones for treatment of diabetes complications1987
2-guanidino-4-heteroarylthiazoles1986
Spiro-3-hetero-azolones for treatment of diabetic complications1985
2-Guanidino-4-heteroarylthiazoles1985
Haloacetyl imidazoles1984
Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process 1984
2-Guanidino-4-heteroarylthiazoles1983